These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7612420)

  • 41. Prevention of osteoporosis in heart transplant recipients: a comparison of calcitriol with calcitonin and pamidronate.
    Bianda T; Linka A; Junga G; Brunner H; Steinert H; Kiowski W; Schmid C
    Calcif Tissue Int; 2000 Aug; 67(2):116-21. PubMed ID: 10920215
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Osteoporosis after liver transplantation.
    Compston JE
    Liver Transpl; 2003 Apr; 9(4):321-30. PubMed ID: 12682881
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bone disease after transplantation: osteoporosis and fractures risk.
    Kulak CA; Borba VZ; Kulak Júnior J; Custódio MR
    Arq Bras Endocrinol Metabol; 2014 Jul; 58(5):484-92. PubMed ID: 25166039
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bone loss and turnover after cardiac transplantation.
    Shane E; Rivas M; McMahon DJ; Staron RB; Silverberg SJ; Seibel MJ; Mancini D; Michler RE; Aaronson K; Addesso V; Lo SH
    J Clin Endocrinol Metab; 1997 May; 82(5):1497-506. PubMed ID: 9141540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk Factors and Management of Osteoporosis Post-Transplant.
    Kovvuru K; Kanduri SR; Vaitla P; Marathi R; Gosi S; Garcia Anton DF; Cabeza Rivera FH; Garla V
    Medicina (Kaunas); 2020 Jun; 56(6):. PubMed ID: 32575603
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Osteoporosis following heart transplantation. Pathogenesis and therapy].
    Stempfle HU
    Dtsch Med Wochenschr; 1996 Sep; 121(36):1103-7. PubMed ID: 8846757
    [No Abstract]   [Full Text] [Related]  

  • 47. Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort.
    Segaud N; Legroux I; Hazzan M; Noel C; Cortet B
    Osteoporos Int; 2018 May; 29(5):1165-1175. PubMed ID: 29500526
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bone Loss after Solid Organ Transplantation: A Review of Organ-Specific Considerations.
    Kim KJ; Ha J; Kim SW; Kim JE; Lee S; Choi HS; Hong N; Kong SH; Ahn SH; Park SY; Baek KH
    Endocrinol Metab (Seoul); 2024 Apr; 39(2):267-282. PubMed ID: 38693817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tacrolimus: a further update of its use in the management of organ transplantation.
    Scott LJ; McKeage K; Keam SJ; Plosker GL
    Drugs; 2003; 63(12):1247-97. PubMed ID: 12790696
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between postoperative erythromycin breath test and early morbidity in liver transplant recipients.
    Schmidt LE; Rasmussen A; Kirkegaard P; Dalhoff K
    Transplantation; 2003 Jul; 76(2):358-63. PubMed ID: 12883193
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Osteoporosis and bone morbidity in cardiac transplant recipients.
    Lee AH; Mull RL; Keenan GF; Callegari PE; Dalinka MK; Eisen HJ; Mancini DM; DiSesa VJ; Attie MF
    Am J Med; 1994 Jan; 96(1):35-41. PubMed ID: 8304361
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.
    Castroagudín JF; Molina E; Romero R; Otero E; Tomé S; Varo E
    Liver Transpl; 2009 Dec; 15(12):1792-7. PubMed ID: 19938140
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Calcitonin and bisphosphonates treatment in bone loss after liver transplantation.
    Valero MA; Loinaz C; Larrodera L; Leon M; Moreno E; Hawkins F
    Calcif Tissue Int; 1995 Jul; 57(1):15-9. PubMed ID: 7671159
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology.
    Valantine H
    J Heart Lung Transplant; 2007 Jun; 26(6):557-64. PubMed ID: 17543777
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
    Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current Status of Research on Osteoporosis after Solid Organ Transplantation: Pathogenesis and Management.
    Lan GB; Xie XB; Peng LK; Liu L; Song L; Dai HL
    Biomed Res Int; 2015; 2015():413169. PubMed ID: 26649301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Timing and quantification of bone loss in cardiac transplant recipients.
    Van Cleemput J; Daenen W; Nijs J; Geusens P; Dequeker J; Vanhaecke J
    Transpl Int; 1995; 8(3):196-200. PubMed ID: 7626179
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Kidney transplantation: prevention and treatment for bone loss after transplantation].
    Kokado Y
    Clin Calcium; 2006 Jan; 16(1):86-91. PubMed ID: 16397356
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety of anidulafungin in solid organ transplant recipients.
    Aguado JM; Varo E; Usetti P; Pozo JC; Moreno A; Catalán M; Len O; Blanes M; Solé A; Muñoz P; Montejo M;
    Liver Transpl; 2012 Jun; 18(6):680-5. PubMed ID: 22328277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.